180
Participants
Start Date
October 22, 2024
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
STN1013800 ophthalmic solution
Investigational Product: 0.1% STN1013800 ophthalmic solution
STN1013800 ophthalmic solution Liquid Base, without STN1013800
Placebo control: STN1013800 ophthalmic solution Liquid Base, without STN1013800
RECRUITING
Anhui Provincial Hospital, Hefei
RECRUITING
The Second Hospital of Anhui Medical University, Hefei
RECRUITING
Beijing Chaoyang Hospital, Capital Medical University, Beijing
NOT_YET_RECRUITING
Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong, Shantou
NOT_YET_RECRUITING
Affiliated Hospital of Guizhou Medical University, Guiyang
RECRUITING
The first affiliated hospital of Zhengzhou University, Zhengzhou
NOT_YET_RECRUITING
The 2nd Affiliated Hospital of Harbin Medical University, Ha’erbin
NOT_YET_RECRUITING
Wuhan Aier Eye Hospital, Wuhan
NOT_YET_RECRUITING
Xiangyang Central Hospital, Xiangyang
NOT_YET_RECRUITING
The second norman bethune hospital of Jilin University, Changchun
NOT_YET_RECRUITING
Dalian No.3 Peple's Hospital, Dali
NOT_YET_RECRUITING
The 4TH People's Hospital of Shenyang, Shenyang
RECRUITING
Shandong Eye Hospital, Jinan
RECRUITING
Eye & Ent Hospital of Fudan University, Shanghai
NOT_YET_RECRUITING
Shanxi Eye Hospital, Taiyuan
RECRUITING
Panzhihua Hospital of Integrated Chinese and Western Medicine, Panzhihua
RECRUITING
Tianjin Eye Hospital, Tianjin
NOT_YET_RECRUITING
Tianjin Medical University Eye Hospital, Tianjin
NOT_YET_RECRUITING
Sir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang University School of Medicine, Hangzhou
NOT_YET_RECRUITING
The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou
NOT_YET_RECRUITING
Eye Hospital, Wenzhou Medical University / Zhejiang Eye Hospital, Wenzhou
Santen Pharmaceutical Co., Ltd.
INDUSTRY